Drug Database
Back to search

United States· US:67184-0572_b4283ace-4312-4cab-97c2-0722339d75b9

Mirabgeorn

A mirabegron product containing mirabegron, registered in United States by Qilu Pharmaceutical Co., Ltd.. The same ATC class is registered in 15 of our 19 countries.

ATC G04BD12

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMirabgeornATCG04BD12REGISTER NO.US:67184-0572_b4283ac…PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mirabegronAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mirabegron is registered in 15 of 19 countries.

Countries holding a registration under ATC G04BD12 (mirabegron), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search mirabegron products by name

Mirabegron · ATC G04BD12

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mirabegron costs, country by country.

Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Mirabegron · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.84
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
MIRABEGRON
Manufacturer
Qilu Pharmaceutical Co., Ltd.
Country
United States (US)
ATC code
G04BD12
ATC class
Mirabegron
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    67184-0572-1
  • ndc11
    67184-0572-2
  • ndc11
    6718405721
    30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-1)
  • ndc11
    6718405722
    90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-2)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

100 interactions on record for mirabegron.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check mirabegron against other medicinesHow interaction checks work

Mirabegron · interactions on record

100 records

  • 3 severe
  • 26 moderate
  • 71 minor

Most severe, free to view

  • EliglustatA16AX10severe
  • VenetoclaxL01XX52severe
  • TamoxifenL02BA01severe
  • TrospiumA03AB20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mirabegron in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mirabegron products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Mirabegron +pharma, Mirabegron G.L.
  • Belgium · Mirabegron Eg, Mirabegron Teva
  • Bulgaria · Иретиг, Мирабегрон G.L.
  • Cyprus · Macitentan, Mirabegron
  • Czechia · Begirax, Iretig
  • Germany · Mirabegron Al, Mirabegron Aristo
  • Denmark · Mirabegron Glenmark, Mirabegron Stada
  • Estonia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
  • Spain · Baxirto, Iretig
  • Finland · Mirabegron Avansor, Mirabegron Glenmark
  • France · Mirabegron Zentiva, Mirabegron Zentiva L.P.
  • United Kingdom (Northern Ireland) · Mirabegron Altair, Mirabegron Aspire
  • Greece · Iretig, Mirabegron Aristo Aristo
  • Croatia · Iretig, Mezyran
  • Hungary · Mirabegron Stada
  • Ireland · Mirabegron Ascend, Mirabegron Clonmel
  • Iceland · Betmiga, Iretig
  • Italy · Iretig, Mirabegron Doc
  • Liechtenstein · Betmiga
  • Lithuania · Mirabegron Zentiva, Mirabegron Zentiva K.S.
  • Luxembourg · Mirabegron Eg
  • Latvia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
  • Malta · Mirabegron, Mirabegron Clonmel
  • Netherlands · Mirabegron Cf, Mirabegron Glenmark
  • Norway · Betmiga, Mirabegron Glenmark
  • Poland · Begirax, Iretig
  • Portugal · Baxirto, Mirabegrom Alter
  • Romania · Iretig, Mirabegron G.L. Pharma
  • Sweden · Mirabegron Avansor, Mirabegron Glenmark
  • Slovenia · Gozi 25 Mg, Gozi 50 Mg
  • Slovakia · Mirabegron Glenmark, Mirabegron Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3e92e026-5d46-41ab-875b-eb94062f5010
GET /v1/drugs/3e92e026-5d46-41ab-875b-eb94062f5010?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "50",
  "substance": "MIRABEGRON",
  "productndc": "67184-0572",
  "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA217989",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about mirabegron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console